The aim of this clinical trial, which has just received approval in France, is to assess the safety and efficacy of a new gene therapy drug in children aged between 6 and 31 months with profound hearing loss.
Blue Cross Expands Access to GI Virtual Care
What You Should Know: Blue Cross Blue Shield of Massachusetts (Blue Cross) today announced that it is growing its network of virtual care providers to treat two